ES2280079T3 - Polipeptidos implicados en la expresion de la resistencia a los antibioticos glicopeptidos. - Google Patents

Polipeptidos implicados en la expresion de la resistencia a los antibioticos glicopeptidos. Download PDF

Info

Publication number
ES2280079T3
ES2280079T3 ES91920753T ES91920753T ES2280079T3 ES 2280079 T3 ES2280079 T3 ES 2280079T3 ES 91920753 T ES91920753 T ES 91920753T ES 91920753 T ES91920753 T ES 91920753T ES 2280079 T3 ES2280079 T3 ES 2280079T3
Authority
ES
Spain
Prior art keywords
seq
sequence
strains
sequences
resistance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91920753T
Other languages
English (en)
Spanish (es)
Inventor
Michel Arthur
Sylvie Dukta-Malen
Catherine Molinas
Patrice Courvalin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of ES2280079T3 publication Critical patent/ES2280079T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES91920753T 1990-10-31 1991-10-29 Polipeptidos implicados en la expresion de la resistencia a los antibioticos glicopeptidos. Expired - Lifetime ES2280079T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9013579A FR2668489A1 (fr) 1990-10-31 1990-10-31 Sequences nucleotidiques et polypeptidiques impliquees dans l'expression de la resistance aux glycopeptides. utilisation pour le diagnostic.
FR9013579 1990-10-31

Publications (1)

Publication Number Publication Date
ES2280079T3 true ES2280079T3 (es) 2007-09-01

Family

ID=9401774

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91920753T Expired - Lifetime ES2280079T3 (es) 1990-10-31 1991-10-29 Polipeptidos implicados en la expresion de la resistencia a los antibioticos glicopeptidos.

Country Status (9)

Country Link
US (1) US6013508A (US08080257-20111220-C00005.png)
EP (2) EP0507934B1 (US08080257-20111220-C00005.png)
JP (3) JP3404533B2 (US08080257-20111220-C00005.png)
CA (3) CA2475116C (US08080257-20111220-C00005.png)
DE (1) DE69133555T2 (US08080257-20111220-C00005.png)
DK (1) DK0507934T3 (US08080257-20111220-C00005.png)
ES (1) ES2280079T3 (US08080257-20111220-C00005.png)
FR (1) FR2668489A1 (US08080257-20111220-C00005.png)
WO (1) WO1992007942A1 (US08080257-20111220-C00005.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2699539B1 (fr) * 1992-12-18 1995-02-17 Pasteur Institut Protéine conférant une résistance de type inductible, à des glycopeptides, notamment chez des bactéries à gram-positif. Séquence de nucléotides codant pour cette protéine.
FR2699537B1 (fr) * 1992-12-18 1995-02-17 Pasteur Institut Protéine conférant une résistance de type inductible, à des glycopeptides, notamment chez des bactéries à gram-positif. Séquences de nucléotides codant pour cette protéine.
US5770690A (en) * 1995-06-27 1998-06-23 Neurex Corporation Bax omega protein and methods
US6107071A (en) * 1996-09-24 2000-08-22 Smithkline Beecham Corporation Histidinol dehydrogenase
US6270992B1 (en) * 1997-07-29 2001-08-07 Smithkline Beecham Corporation Histidine kinase of Staphylococcus aureus
WO2001012803A2 (en) * 1999-08-17 2001-02-22 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for restoring antibiotic susceptibility in glycopeptide-resistant enterococcus
AU2006272776B2 (en) 2005-07-21 2012-01-19 Ibis Biosciences, Inc. Methods for rapid identification and quantitation of nucleic acid variants
WO2011029034A2 (en) * 2009-09-04 2011-03-10 Intelligent Medical Devices, Inc. Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of vancomycin resistance genes and vancomycin resistant enterococci
FR2994270B1 (fr) 2012-08-01 2020-01-03 Biomerieux Procede de detection d'au moins un mecanisme de resistance aux glycopeptides par spectrometrie de masse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606043B2 (en) * 1985-03-28 1991-01-31 F. Hoffmann-La Roche Ag Detection of viruses by amplification and hybridization
FR2699537B1 (fr) * 1992-12-18 1995-02-17 Pasteur Institut Protéine conférant une résistance de type inductible, à des glycopeptides, notamment chez des bactéries à gram-positif. Séquences de nucléotides codant pour cette protéine.

Also Published As

Publication number Publication date
DK0507934T3 (da) 2007-05-14
JPH05503222A (ja) 1993-06-03
CA2072350A1 (fr) 1992-05-01
DE69133555T2 (de) 2007-10-25
EP1785487A2 (fr) 2007-05-16
CA2475116A1 (fr) 1992-05-14
DE69133555D1 (de) 2007-02-22
WO1992007942A1 (fr) 1992-05-14
JP2002320494A (ja) 2002-11-05
CA2637710A1 (fr) 1992-05-14
EP0507934A1 (fr) 1992-10-14
FR2668489B1 (US08080257-20111220-C00005.png) 1995-03-31
JP4128905B2 (ja) 2008-07-30
EP0507934B1 (fr) 2007-01-10
US6013508A (en) 2000-01-11
CA2072350C (fr) 2004-11-30
CA2637710C (fr) 2010-12-14
EP1785487A3 (fr) 2012-01-11
JP2004024251A (ja) 2004-01-29
FR2668489A1 (fr) 1992-04-30
JP3404533B2 (ja) 2003-05-12
CA2475116C (fr) 2008-12-02

Similar Documents

Publication Publication Date Title
Martínez‐Bueno et al. Analysis of the gene cluster involved in production and immunity of the peptide antibiotic AS‐48 in Enterococcus faecalis
Depardieu et al. The vanG glycopeptide resistance operon from Enterococcus faecalis revisited
Abadía Patiño et al. vanE gene cluster of vancomycin-resistant Enterococcus faecalis BM4405
Arias et al. vanC cluster of vancomycin-resistant Enterococcus gallinarum BM4174
Strockbine et al. Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1
Bessen et al. Nucleotide sequences of two adjacent M or M-like protein genes of group A streptococci: different RNA transcript levels and identification of a unique immunoglobulin A-binding protein
Brahamsha et al. Identification of multiple RNA polymerase sigma factor homologs in the cyanobacterium Anabaena sp. strain PCC 7120: cloning, expression, and inactivation of the sigB and sigC genes
Chang et al. Overproduction, purification, and characterization of Bacillus subtilis RNA polymerase sigma A factor
Lally et al. Identification and immunological characterization of the domain of Actinobacillus actinomycetemcomitans leukotoxin that determines its specificity for human target cells.
Melville et al. Expression from the Clostridium perfringens cpe promoter in C. perfringens and Bacillus subtilis
Garnier et al. Characterization of a bacteriocinogenic plasmid from Clostridium perfringens and molecular genetic analysis of the bacteriocin-encoding gene
JPH08509873A (ja) ヘリコバクター感染に対する免疫組成物、該組成物に用いられるポリペプチドおよび該ポリペプチドをコードする核酸配列
Karunakaran et al. Isolation and characterization of a hemin-regulated gene, hemR, from Porphyromonas gingivalis
Bangsborg et al. Nucleotide sequence analysis of the Legionella micdadei mip gene, encoding a 30-kilodalton analog of the Legionella pneumophila Mip protein
Bossé et al. Novel genes affecting urease activity in Actinobacillus pleuropneumoniae
Lambert et al. Characterization of Acinetobacter haemolyticus aac (6')-Ig gene encoding an aminoglycoside 6'-N-acetyltransferase which modifies amikacin
Pag et al. Molecular analysis of expression of the lantibiotic Pep5 immunity phenotype
Carlsson et al. Genetic characterization of Bacillus subtilis odhA and odhB, encoding 2-oxoglutarate dehydrogenase and dihydrolipoamide transsuccinylase, respectively
ES2280079T3 (es) Polipeptidos implicados en la expresion de la resistencia a los antibioticos glicopeptidos.
Isnard et al. Maturation and localization of the TolB protein required for colicin import
Langford et al. Cloning and molecular characterization of Cu, Zn superoxide dismutase from Actinobacillus pleuropneumoniae
Brehm et al. A gene encoding a superoxide dismutase of the facultative intracellular bacterium Listeria monocytogenes
Alderete et al. Only two of theTrichomonas vaginalistriplet AP51 adhesins are regulated by iron
Broome‐Smith et al. Production of thiol‐penicillin‐binding protein 3 of Escherichia coli using a two primer method of site‐directed mutagenesis.
WO1995025738A1 (en) Recombinase-deficient helicobacter pylori and related methods